Blueberries Medical Corp.
BBM
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -31.26% | -34.50% | 51.18% | 47.58% | 41.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -31.26% | -34.50% | 51.18% | 47.58% | 41.29% |
| Cost of Revenue | -45.55% | -47.07% | 90.98% | 36.01% | 44.10% |
| Gross Profit | -7.85% | -11.23% | 11.31% | 68.39% | 36.99% |
| SG&A Expenses | -41.86% | 42.49% | 17.40% | 19.44% | 11.81% |
| Depreciation & Amortization | -28.97% | -8.46% | -12.64% | -45.98% | -38.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.66% | 18.93% | 22.03% | 13.53% | 10.45% |
| Operating Income | 44.88% | -46.24% | -15.12% | -5.63% | -3.43% |
| Income Before Tax | 35.75% | -41.33% | -31.25% | -14.90% | -10.05% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.75% | -41.33% | -31.25% | -14.90% | -10.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.75% | -41.33% | -31.25% | -14.90% | -10.05% |
| EBIT | 44.88% | -46.24% | -15.12% | -5.63% | -3.43% |
| EBITDA | 46.17% | -53.33% | -17.98% | -14.53% | -9.09% |
| EPS Basic | 48.28% | -23.81% | 3.70% | 25.71% | 36.96% |
| Normalized Basic EPS | 50.00% | -27.27% | -7.69% | 22.22% | 36.00% |
| EPS Diluted | 48.28% | -23.81% | 3.70% | 25.71% | 36.96% |
| Normalized Diluted EPS | 50.00% | -27.27% | -7.69% | 22.22% | 36.00% |
| Average Basic Shares Outstanding | 26.41% | 21.30% | 26.44% | 37.13% | 51.48% |
| Average Diluted Shares Outstanding | 26.41% | 21.30% | 26.44% | 37.13% | 51.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |